H00004016-B01P

antibody from Abnova Corporation

Targeting: LOXL1 LOL, LOXL

Provider product page for H00004016-B01P

Western blot

Antibody data

Antibody Data
Antigen structure
References [2]
Comments [0]
Validations
Western blot [1]

Submit

Product number: H00004016-B01P - Provider product page
Provider: Abnova Corporation
Proper citation: Abnova Corporation Cat#H00004016-B01P, RRID:AB_1576867
Product name: LOXL1 purified MaxPab mouse polyclonal antibody (B01P)
Antibody type: Polyclonal
Description: Mouse polyclonal antibody raised against a full-length human LOXL1 protein.
Antigen sequence: MALARGSRQLGALVWGACLCVLVHGQQAQPGQGSD PARWRQLIQWENNGQVYSLLNSGSEYVPAGPQRSE SSSRVLLAGAPQAQQRRSHGSPRRRQAPSLPLPGR VGSDTVRGQARHPFGFGQVPDNWREVAVGDSTGMA RARTSVSQQRHGGSASSVSASAFASTYRQQPSYPQ QFPYPQAPFVSQYENYDPASRTYDQGFVYYRPAGG GVGAGAAAVASAGVIYPYQPRARYEEYGGGEELPE YPPQGFYPAPERPYVPPPPPPPDGLDRRYSHSLYS EGTPGFEQAYPDPGPEAAQAHGGDPRLGWYPPYAN PPPEAYGPPRALEPPYLPVRSSDTPPPGGERNGAQ QGRLSVGSVYRPNQNGRGLPDLVPDPNYVQASTYV QRAHLYSLRCAAEEKCLASTAYAPEATDYDVRVLL RFPQRVKNQGTADFLPNRPRHTWEWHSCHQHYHSM DEFSHYDLLDAATGKKVAEGHKASFCLEDSTCDFG NLKRYACTSHTQGLSPGCYDTYNADIDCQWIDITD VQPGNYILKVHVNPKYIVLESDFTNNVVRCNIHYT GRYVSATNCKIVQS
Storage: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

LOXL1 protein structure - H00004016-B01P shown in red.

Submitted references A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome.

Aung T, Ozaki M, Mizoguchi T, Allingham RR, Li Z, Haripriya A, Nakano S, Uebe S, Harder JM, Chan AS, Lee MC, Burdon KP, Astakhov YS, Abu-Amero KK, Zenteno JC, Nilgün Y, Zarnowski T, Pakravan M, Safieh LA, Jia L, Wang YX, Williams S, Paoli D, Schlottmann PG, Huang L, Sim KS, Foo JN, Nakano M, Ikeda Y, Kumar RS, Ueno M, Manabe S, Hayashi K, Kazama S, Ideta R, Mori Y, Miyata K, Sugiyama K, Higashide T, Chihara E, Inoue K, Ishiko S, Yoshida A, Yanagi M, Kiuchi Y, Aihara M, Ohashi T, Sakurai T, Sugimoto T, Chuman H, Matsuda F, Yamashiro K, Gotoh N, Miyake M, Astakhov SY, Osman EA, Al-Obeidan SA, Owaidhah O, Al-Jasim L, Al Shahwan S, Fogarty RA, Leo P, Yetkin Y, Oğuz Ç, Kanavi MR, Beni AN, Yazdani S, Akopov EL, Toh KY, Howell GR, Orr AC, Goh Y, Meah WY, Peh SQ, Kosior-Jarecka E, Lukasik U, Krumbiegel M, Vithana EN, Wong TY, Liu Y, Koch AE, Challa P, Rautenbach RM, Mackey DA, Hewitt AW, Mitchell P, Wang JJ, Ziskind A, Carmichael T, Ramakrishnan R, Narendran K, Venkatesh R, Vijayan S, Zhao P, Chen X, Guadarrama-Vallejo D, Cheng CY, Perera SA, Husain R, Ho SL, Welge-Luessen UC, Mardin C, Schloetzer-Schrehardt U, Hillmer AM, Herms S, Moebus S, Nöthen MM, Weisschuh N, Shetty R, Ghosh A, Teo YY, Brown MA, Lischinsky I, Blue Mountains Eye Study GWAS Team, Wellcome Trust Case Control Consortium 2, Crowston JG, Coote M, Zhao B, Sang J, Zhang N, You Q, Vysochinskaya V, Founti P, Chatzikyriakidou A, Lambropoulos A, Anastasopoulos E, Coleman AL, Wilson MR, Rhee DJ, Kang JH, May-Bolchakova I, Heegaard S, Mori K, Alward WL, Jonas JB, Xu L, Liebmann JM, Chowbay B, Schaeffeler E, Schwab M, Lerner F, Wang N, Yang Z, Frezzotti P, Kinoshita S, Fingert JH, Inatani M, Tashiro K, Reis A, Edward DP, Pasquale LR, Kubota T, Wiggs JL, Pasutto F, Topouzis F, Dubina M, Craig JE, Yoshimura N, Sundaresan P, John SW, Ritch R, Hauser MA, Khor CC
Nature genetics 2015 Apr;47(4):387-92

LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.

Schlötzer-Schrehardt U, Hammer CM, Krysta AW, Hofmann-Rummelt C, Pasutto F, Sasaki T, Kruse FE, Zenkel M
Ophthalmology 2012 Sep;119(9):1832-43